Sabra Healthcare (SBRA) reported $182.35 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 11.6%. EPS of $0.36 for the same period compares to $0.07 ...

BofA analyst Jeffrey Spector lowered the firm’s price target on Sabra Health Care (SBRA) to $20 from $21 and keeps a Buy rating on the shares.

As of September 30, 2024, Sabra’s investment portfolio included 373 real estate properties held for investment (consisting of (i) 233 skilled nursing/transitional care facilities, (ii) 39 senior ...

SBRA currently has a PEG ratio of 1.99. Another notable valuation metric for CHCT is its P/B ratio of 1.15. The P/B is a method of comparing a stock's market value to its book value, which is ...

SBRA stock trades at a reasonable valuation with a forward P/FFO of 12.2, positioning it for potential market-beating total returns. Looking for a portfolio of ideas like this one? Members of ...

Wells Fargo analyst James Feldman maintained a Buy rating on Sabra Healthcare REIT (SBRA – Research Report) today and set a price target of $20.00. The company’s shares closed last Friday at ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

SILA Sila Realty Trust, Inc.